May 17, 2024

Treatments, Interventions & Exercise

Maintenance low dose systemic glucocorticoids have limited impact on bone strength and mineral density among incident renal allograft recipients: A pilot prospective cohort study

María José Pérez-Sáez 1, Sabina Herrera 2, Daniel Prieto-Alhambra 3, Laia Vilaplana 2, Xavier Nogués 2, María Vera 4, Dolores Redondo-Pachón 1, Marisa Mir 4, Roberto Güerri 2, Marta Crespo 1, Adolfo Díez-Pérez 2, Julio Pascual 5 Bone. 2018 Nov;116:290-294. doi: 10.1016/j.bone.2018.08.013. Epub 2018 Aug 23.

Treatments, Interventions & Exercise

Bone density, microarchitecture, and tissue quality after 1 year of treatment with tenofovir disoproxil fumarate

Robert Güerri-Fernández 1 2, Elisabet Lerma-Chippirraz 1 2, Ana Fernandez Marron 1, Natalia García-Giralt 1, Judit Villar-García 1, Jade Soldado-Folgado 1, Alicia González-Mena 1, Marta Trenchs-Rodríguez 3, Ana Guelar 1, Adolfo Díez-Pérez 1 2, Todd T Brown 4, Hernando Knobel 1 2 AIDS. 2018 Apr 24;32(7):913-920. doi: 10.1097/QAD.0000000000001780.PMID: 29424785 DOI: 10.1097/QAD.0000000000001780

Treatments, Interventions & Exercise

Bone Density, Microarchitecture, and Tissue Quality Long-term After Kidney Transplant

María José Pérez-Sáez 1, Sabina Herrera, Daniel Prieto-Alhambra, Xavier Nogués, María Vera, Dolores Redondo-Pachón, Marisa Mir, Roberto Güerri, Marta Crespo, Adolfo Díez-Pérez, Julio Pascual Transplantation. 2017 Jun;101(6):1290-1294. doi: 10.1097/TP.0000000000001328. PMID: 27467533 DOI: 10.1097/TP.0000000000001328 Background: Bone

Treatments, Interventions & Exercise

Bone Density, Microarchitecture, and Tissue Quality After Long-Term Treatment With Tenofovir/Emtricitabine or Abacavir/Lamivudine

Robert Güerri-Fernández 1, Daniel Molina-Morant, Judit Villar-García, Sabina Herrera, Alicia González-Mena, Ana Guelar, Marta Trenchs-Rodríguez, Adolfo Díez-Pérez, Hernando Knobel J Acquir Immune Defic Syndr. 2017 Jul 1;75(3):322-327. doi: 10.1097/QAI.0000000000001396. PMID: 28418990 DOI: 10.1097/QAI.0000000000001396

Scroll to Top

This website uses cookies to enhance the user experience. By using this site you agree to our privacy policy

This website uses cookies to enhance the user experience. By using this site you agree to our privacy policy